Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06572306 · ClinicalTrials.gov registry record

Pharmacist-led Continuous Glucose Monitoring

A clinical trial of Type 2 Diabetes, sponsored by University of South Florida.

Recruiting
Registry status
20
Enrollment target
2
Study locations

NCT06572306 is a study of Type 2 Diabetes that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 20 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06572306, a study of Type 2 Diabetes, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in people with type 2 diabetes using continuous glucose monitoring under a pharmacist-led approach as compared to a pharmacist-led approach utilizing no continuous glucose monitoring (only self-monitoring blood glucose with a glucometer). 2. to assess change in continuous glucose monitoring-derived glycemic outcomes among the pharmacist-led continuous glucose monitoring cohort (intervention group) 3. to assess change in health behavior among the pharmacist-led continuous glucose monitoring cohort (intervention group)

Conditions Studied

Type 2 Diabetes

Interventions

  • DEVICE FreeStyle Libre 2 Continuous Glucose Monitor

Study Locations (2)

Florida

  • USF Health Department of Family Medicine - Morsani Center for Advanced Health Care - Tampa
  • USF Health Department of Family Medicine - University Partnership Center - Tampa

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-09-01
Est. Completion 2025-08-05

Sponsor

University of South Florida

252 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06572306

The ClinicalTrials.gov registry entry for NCT06572306 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 1 intervention - of which FreeStyle Libre 2 Continuous Glucose Monitor is the first listed.

NCT06572306 reports 2 study locations spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06572306 about?

NCT06572306 is a clinical study titled "Pharmacist-led Continuous Glucose Monitoring". This is a pilot study. The goal of this prospective cohort study is to determine impact of pharmacist-led continuous glucose monitoring on glycemic control and health behavior change in people with type 2 diabetes. The main questions it aims to answer are: 1. to assess change in hemoglobin A1c in p...

What is the current status of trial NCT06572306?

This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2024-09-01. Estimated completion is 2025-08-05.

What conditions does trial NCT06572306 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT06572306?

The interventions under investigation include: FreeStyle Libre 2 Continuous Glucose Monitor (DEVICE).

Who is sponsoring clinical trial NCT06572306?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06572306 being conducted?

This trial has 2 study locations across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.